Accueilhttps://www.statnews.comSTAT+: In surprise decision, FDA rejects radiopharma therapy expected to rival Novartis treatmentSTAT+: In surprise decision, FDA rejects radiopharma therapy expected to rival Novartis treatmenthttps://www.statnews.com • Publié le 10 août 2026🇬🇧 → 🇫🇷 PDF Extrait J'aime Je n'aime pas Suivre Source The FDA has rejected a radiopharmaceutical therapy because of manufacturing issues, halting what would have been a competitor for Novartis.Espace publicitaire · 300×250